Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
| Metric | ABBV | ABT |
|---|
| Close | 262.51 | 102.36 |
| Market Cap | $464B | $177B |
| 1M | +4.87% | −7.26% |
| P/E (TTM) | 73.7 | 33.2 |
| Forward P/E | 16.8 | 18.1 |
| P/E 5-Yr Percentile | 51 | 66 |
| P/S | 7.2 | 3.9 |
| P/B | — | 3.5 |
| Dividend Yield | 4.47% | 1.98% |
| Latest Quarter Revenue | $17.0B | $11.2B |
| Revenue YoY | +10.2% | +7.8% |
| Gross Margin | 74.7% | 56.2% |
| Latest Quarter EPS | 2.03 | 0.61 |
| Avg Post-Earnings Move | ±1.7% | ±1.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.81% |
| 90-Day Net Insider Buying | −$8.2M | −$46.7M |
ABBV · Revenue, Last 8 Quarters ($B)
ABT · Revenue, Last 8 Quarters ($B)
